Our blog

A startup dental aligner manufacturer was looking to launch in the US and as part of its ambitious growth plans, the company needed to establish a field sales team. These roles have been critical to the startup's US growth and one of our candidates is their top performing sales representative.

For sales, field service and field application employees, travel restrictions have given an insight into a new way of working. As a result, we are seeing an increasing trend of people looking for a better balance, but is this something companies are willing to offer?

Before Brexit, the UK could hire QPs from any location within the EU, but now we can only hire QPs based in the UK – resulting in a lack of supply and a rise in day-rates and salaries. We spoke to the Vice President of Quality at a global biotechnology organisation about the challenges of hiring QPs within the UK, and how these might be overcome.

Are you a life science company looking to expand into the US? To find out more about what you should consider, we interviewed Joanne Farquharson, President & Chief Executive Officer at Foothold America, a company that helps businesses around the world to expand into the US market.

In the US, we are beginning to see the start of the predicted ‘turnover tsunami’ and it might not be long until we see something similar across Europe and the UK. But why is this happening and what can employers do to not only retain existing employees but to also attract those individuals looking for a change of career?

An established pharmaceutical company in Europe that develops, manufactures and markets generic medications planned to continue its growth strategy by opening a new subsidiary to target the US generics market. To develop and commercialise a portfolio of generic drugs to market, the company needed a US General Manager.

Have you ever felt like you are out of your depth or can’t do the job you’ve been hired to do? Do you worry you will be discovered at any point as a ‘fraud’? You may be suffering from impostor syndrome: a phenomenon where an individual doubts their skills, talents, abilities, and accomplishments in the face of obvious success.

In 2019, the US biosimilar market was worth $737.2 million and continues to grow with a CAGR of 46.2% forecast for 2020-2027, however many are frustrated at the current rate of adoption in the US. But with increasing healthcare costs and a growing debt from Covid-19, what does the next year hold for biosimilar adoption across the US?

As part of our ‘Female Leaders: Inspiring Together’ series, we interviewed Elizabeth A Crocker – Chief Executive Officer & Data Protection Officer at CLEWS Medical Limited – about her career journey from her early days as a nurse, to owning her own business to now leading the commercial direction of a Med Tech startup.